Tissue-of-origin-specific gene repositioning in breast and prostate cancer

被引:22
|
作者
Meaburn, Karen J. [1 ]
Agunloye, Olufunmilayo [1 ]
Devine, Michelle [1 ]
Leshner, Marc [1 ]
Roloff, Gregory W. [1 ]
True, Lawrence D. [2 ]
Misteli, Tom [1 ]
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
Nuclear architecture; Spatial gene positioning; Breast cancer; Prostate cancer; Tissue specificity; ORDER CHROMATIN ARRANGEMENTS; NUCLEAR LAMINA INTERACTIONS; INTERPHASE NUCLEI; HUMAN-CHROMOSOMES; CELL-NUCLEI; SPATIAL-ORGANIZATION; GENOME ORGANIZATION; INACTIVE GENES; TERRITORIES; DIFFERENTIATION;
D O I
10.1007/s00418-015-1401-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Genes have preferential non-random spatial positions within the cell nucleus. The nuclear position of a subset of genes differ between cell types and some genes undergo repositioning events in disease, including cancer. It is currently unclear whether the propensity of a gene to reposition reflects an intrinsic property of the locus or the tissue. Using quantitative FISH analysis of a set of genes which reposition in cancer, we test here the tissue specificity of gene repositioning in normal and malignant breast or prostate tissues. We find tissue-specific organization of the genome in normal breast and prostate with 40 % of genes occupying differential positions between the two tissue types. While we demonstrate limited overlap between gene sets that repositioned in breast and prostate cancer, we identify two genes that undergo disease-related gene repositioning in both cancer types. Our findings indicate that gene repositioning in cancer is tissue-of-origin specific.
引用
收藏
页码:433 / 446
页数:14
相关论文
共 50 条
  • [31] Comparison of prostate specific adenoviral vectors for prostate cancer gene therapy
    Zhang, Y
    Stein, R
    Wang, W
    Steiner, MS
    Lu, Y
    TUMOR TARGETING, 1999, 4 (03): : 158 - 169
  • [32] Prostate-specific antigen gene polymorphism and prostate cancer risk
    Sivonova, M.
    Matakova, T.
    Dobrota, D.
    Hatok, J.
    Kliment, J., Jr.
    Tomaskin, R.
    Kliment, J.
    EJC SUPPLEMENTS, 2008, 6 (03): : 53 - 54
  • [33] Drug Repositioning for Effective Prostate Cancer Treatment
    Turanli, Beste
    Grotli, Morten
    Boren, Jan
    Nielsen, Jens
    Uhlen, Mathias
    Arga, Kazim Y.
    Mardinoglu, Adil
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [35] Targeted-specific gene therapy for prostate cancer
    Paik, SH
    Bui, M
    Pantuck, A
    Belldegrun, A
    CANCER GENE THERAPY, 2001, 8 : S18 - S18
  • [36] Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigenTARP
    Carlsson, B
    Tötterman, TH
    Essand, M
    PROSTATE, 2004, 61 (02): : 161 - 170
  • [37] Differential gene expression in noncancerous prostate tissue of men with and without prostate cancer
    Schlomm, T
    Erbersdobler, A
    Eichelberg, C
    Haese, A
    Heinzer, H
    Poustka, A
    Friedrich, MG
    Graefen, M
    Huland, H
    Sültmann, H
    JOURNAL OF UROLOGY, 2005, 173 (04): : 123 - 123
  • [39] Drug repositioning in cancer: a role for antihistamines in breast cancer?
    Nilbert, Mef
    Mellemkjaer, Lene
    ACTA ONCOLOGICA, 2020, 59 (09) : 1007 - 1008
  • [40] Role of tissue polypeptide specific antigen in the detection of prostate cancer
    Onur, R
    Orhan, I
    Ilhan, N
    Semercioz, A
    UROLOGIA INTERNATIONALIS, 2002, 69 (04) : 278 - 282